Triazoloquinazolines for the treatment of central nervous disorders

US5612344A · kind A · utility

Assignee

• BASF SE

Inventors

• Rainer Schlecker · Bissersheim, DE
• Hans-Joerg Treiber · Zeven, DE
• Berthold Behl · Ludwigshafen, DE
• Hans P. Hofmann · Schifferstadt, DE

Key dates

• Filing date: May 12, 1995
• Grant date: Mar 18, 1997
• Expiry date: May 12, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The use of triazoloquinazolines for the production of drugs for controlling central nervous disorders is described. The triazoloquinazolines have the formula ##STR1## where R.sup.1, R.sup.2 and X have the meanings stated in the description.